Recall On Medication 2024. In january 2024, the following letters were sent or provided to relevant healthcare professionals: Refixia® 3000 iu powder and solvent for solution for injection (nonacog beta pegol):
The company also recalled a 1% lidocaine hci injection lot with a june 2024 expiration date and a 2% lidocaine hci injection lot with a july 2024 expiration date. Pfizer has recalled a blood pressure medication under three names over concerns they are tainted with a possible carcinogen.
The Company Also Recalled A 1% Lidocaine Hci Injection Lot With A June 2024 Expiration Date And A 2% Lidocaine Hci Injection Lot With A July 2024 Expiration Date.
Learn about ndma and your next steps if there's another recall.
Between July 2018 And September 2019, The U.s.
Food and drug administration has issued a class 1 recall—its most urgent kind—for an ios app linked to a specific kind of insulin pump used by people with diabetes.
In March 2024, Recalls And Notifications For Medicines Were Issued On:
Images References :
12 March 2024 Class 2 Medicines Recall:
Search list of recalled angiotensin ii receptor blockers (arbs) including valsartan, losartan and irbesartan.
In February 2024, The Following Letters Were Sent Or Provided To Relevant Healthcare Professionals:
Medac gmbh (t/a medac pharma llp), sodiofolin 50 mg/ml, solution for injection/infusion (folinic acid 400mg/8ml vial), el(24)a/08